Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $10,825 | $8,786 | $6,897 | $50,478 |
| Gross profit | $2.6M | $3.1M | $3.3M | $3.9M |
| Research & development | $777,695 | $634,046 | $630,752 | $492,526 |
| Operating expenses | $3.0M | $8.2M | $1.6M | $1.6M |
| Operating income | −$423,048 | −$5.1M | $1.7M | $2.4M |
| EBITDAderived | $184,374 | −$4.6M | $2.1M | $2.6M |
| Net income | −$1.8M | −$5.7M | $1.5M | $2.1M |
| Basic EPSper diluted share | — | -$194.28 | $54.92 | $0.43 |
| Diluted EPSper diluted share | — | -$194.28 | $54.92 | $0.43 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 13, 2026Form 4 · 10b5-1 | Xu YingkaiChief Executive Officer | BuyClass A Ordinary Share, par value $0.002 per share | 1.52M | $0.25 | $380.0K | 1.52M |